- CVS Caremark names Helena Foulkes EVP, chief healthcare strategy and marketing officer
- Merlo puts stamp on his leadership in fourth-quarter earnings call
- CVS' Bloom, Baker to lead chain's retail business on interim basis
- Adherence among chronic disease patients can lead to big savings
- MinuteClinic forms clinical collaboration with St. Rose Dominican Hospitals
WOONSOCKET, R.I. — CVS Caremark has been awarded Pharmacy Benefit Management and Drug Therapy Management accreditation from URAC, a Washington, D.C.-based healthcare accrediting organization that establishes quality standards for the healthcare industry, the pharmacy retailer has announced.
"CVS Caremark is pleased to receive these accreditations," stated Jon Roberts, president of CVS Caremark's PBM business. "This provides further validation of the company's ongoing focus and commitment to patient care, outstanding customer service and overall quality."
URAC's PBM Accreditation standards cover the organization's contract terms and pricing structures; ensure access to drugs and pharmacies; provide for drug utilization management, formulary management, patient safety and customer service; and create a process for PBM outcomes measurement and quality improvement.
URAC's DTM Accreditation standards cover the essential parts of a DTM business, including driving appropriate therapeutic outcomes for consumers and reducing adverse events; promoting rational, clinically appropriate, safe and cost-effective DTM through evidence-based medicine; encouraging communication about medication use; supporting population specification, consumer identification and recruitment; and creating a process for DTM outcomes measurement and quality improvement.